Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSOLIGENIX, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

SOLIGENIX, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
    Aug 7, 2026Soligenix Investor Relations
  • Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
    Jun 8, 2026Soligenix Investor Relations
  • Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
    May 26, 2026Soligenix Investor Relations
  • Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
    May 8, 2026Soligenix Investor Relations
  • Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
    Apr 28, 2026Soligenix Investor Relations
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.39Close · Sep 22, 2026